Skip to main content
. 2019 Jan 10;8(3):1535293. doi: 10.1080/2162402X.2018.1535293

Figure 5.

Figure 5.

Composition of tumor-infiltrating lymphocytes in tumors stratified according to serological TAA antibody detection.

Single cell suspensions from HNSCC tumor tissue (n = 38) were analyzed for B and T cell antigens by flow cytometry. Patients were stratified according to serological antibody detection against 23 TAAs in TAA (no antibody response detected) and TAA+ (detection of antibodies against at least one investigated TAA). (A) The fraction of CD19+/CD20+ B cells (left) and plasmacells (CD27+/CD38hi/CD138hi/CD20; right) in the microenvironment of TAA and TAA+ tumors is displayed in scatter plots. (B) Proportions of CD3+ T cells within the CD45+ lymphocyte fraction are shown in scatter plots in TAA/+ tumors. (C) Scatter plots demonstrate fractions of CD8+ T cells (left), CD4+ T cells (middle) and T helper cells (CXCR5+/CD45RA/CCR7) in percent of CD4+ T cells (right) in TAA/+ HNSCC. For statistical analysis, Mann-Whitney test was performed in (A), t test in (B) and (C). Data is presented as mean. *P < 0.05; **P < 0.005; ns, not significant.